Acquisition of HIV type 1 resistance by β-chemokine-producing CD4+ T cells

AIDS Research and Human Retroviruses

Volumn 15, Issue 16, 1999, Pages 1453-1460

  Maeda, Naoyoshi ^a   Koyanagi, Yoshio ^a,b   Misawa, Naoko ^a   Miyano Kurosaki, Naoko ^a   Kira, Jun Ichi ^c   Yamamoto, Naoki ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CHEMOKINE; CHEMOKINE RECEPTOR CCR5; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; NEUTRALIZING ANTIBODY; RANTES;

ARTICLE; CASE REPORT; CYTOKINE PRODUCTION; FLOW CYTOMETRY; HELPER CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RESISTANCE; MONONUCLEAR CELL; PRIORITY JOURNAL; VIRUS INHIBITION;

CD4-POSITIVE T-LYMPHOCYTES; CHEMOKINES, CC; CLONE CELLS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HIV INFECTIONS; HIV-1; HUMANS; NEUTRALIZATION TESTS;

EID: 0033230356     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/088922299309964     Document Type: Article

References (38)

1. Ho DD, Neumann AU, Perelson AS, Chen W, Leonard JM, and Markowitz M: Rapid turnover of plasma virions and CD4 lymphocytes in HIV infection. Nature (London) 1995;373:123-126.
2. Wei X, Ghosh SK, Taylor ME, Johnson VA, Emini EA, Deutsch P, Lifson JD, Bonhoeffer S, Nowak MA, Hahn BH, Saag MS, and Shaw GM: Viral dynamics in human immunodeficiency virus type 1 infection. Nature (London) 1995;373:117-122.
3. Perelson AS, Neumann AU, Markowitz M, Leonard JM, and Ho DD: HIV-1 dynamics in vivo: Virion clearance rate, infected cell life-span, and viral generation time. Science 1996;271:1582-1586.
4. Piatak M Jr, Saag MS, Yang LC, Clark SJ, Kappes JC, Luk KC, Hahn BH, Shaw GM, and Lifson JD: High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR. Science 1993;259:1749-1754.
5. Coffin JM: HIV population dynamics in vivo: Implications for genetic variation, pathogenesis, and therapy. Science 1995;267:483-489.
6. Finzi D and Siliciano RF: Viral dynamics in HIV-1 infection. Cell 1998;93:665-671.
7. + T cells. Science 1995;270:1811-1815.
8. Mackewicz CE, Barker E, and Levy JA: Role of β-chemokines in suppressing HIV replication. Science 1996;274:1393-1394.
9. Arenzana-Seisdedos F, Virelizier JL, Rousset D, Clark-Lewis I, Loetscher P, Moser B, and Baggiolini M: HIV blocked by chemokine antagonist. Nature (London) 1996;383:400.
10. Deng H, Liu R, Ellmeier W, Choe S, Unutmaz D, Burkhart M, Marzio PD, Marmon S, Sutton RE, Hill CM, Davis CB, Peiper SC, Schall TJ, Littman DR, and Landau NR: Identification of a major co-receptor for primary isolates of HIV-1. Nature (London) 1996; 381:661-666.
11. + cells is mediated by the chemokine receptor CC-CKR-5. Nature (London) 1996;381:667-673.
12. Alkhatib G, Combadiere C, Broder CC, Feng Y, Kennedy PE, Murphy PM, and Berger EA: CC CKR5: A RANTES, MIP-1α, MIP-1β receptor as a fusion cofactor for macrophage-tropic HIV-1. Science 1996;272:1955-1958.
13. Choe H, Farzan M, Sun Y, Sullivan N, Rollins B, Ponath PD, Wu L, Mackay CR, LaRosa G, Newman W, Gerard N, Gerard C, and Sodroski J: The β-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell 1996;85:1135-1148.
14. Bleul CC, Farzan M, Choe H, Parolin C, Clark-Lewis I, Sodroski J, and Springer TA: The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry. Nature (London) 1996;382:829-833.
15. Oberlin E, Amara A, Bachelerie F, Bessia C, Virelizier JL, Arenzana-Seisdedos F, Schwartz O, Heard JM, Clark-Lewis I, Legler DF, Loetscher M, Baggiolini M, and Moser B: The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1. Nature (London) 1996;382: 833-835.
16. Loetscher M, Geiser T, O'Reilly T, Zwahlen R, Baggiolini M, and Moser B: Cloning of a human seven-transmembrane domain receptor, LESTR, that is highly expressed in leukocytes. J Biol Chem 1994;269:232-237.
17. Feng Y, Broder CC, Kennedy PE, and Berger EA: HIV-1 entry co-factor: Functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science 1996;272:872-877.
18. + T cells in vitro and in vivo. J Virol 1997;71:8456-8466.
19. Correale J, McMillan M, McCarthy K, Le T, and Weiner LP: Isolation and characterization of autoreactive proteolipid protein-peptide specific T-cell clones from multiple sclerosis patients. Neurology 1995;45:1370-1378.
20. Koyanagi Y, Itoyama Y, Nakamura N, Takamatsu K, Kira J, Iwamasa T, Goto I, and Yamamoto N: In vivo infection of human T-cell leukemia virus type I in non-T cells. Virology 1993;196:25-33.
21. Koyanagi Y, Miles S, Mitsuyasu RT, Merrill JE, Vinters HV, and Chen ISY: Dual infection of the central nervous system by AIDS viruses with distinct cellular tropisms. Science 1987;236:819-822.
22. Adachi A, Gendelman HE, Koenig S, Folks T, Willey R, Rabson A, and Martin MA: Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone. J Virol 1986;59: 284-291.
23. Takeshita T, Goto Y, Tada K, Nagata K, Asao H, and Sugamura K: Monoclonal antibody defining a molecule possibly identical to the p75 subunit of interleukin 2 receptor. J Exp Med 1989;169: 1323-1332.
24. Ishii N, Takeshita T, Kimura Y, Tada K, Kondo M, Nakamura M, and Sugamura K: Expression of the IL-2 receptor γ chain on various populations in human peripheral blood. Int Immunol 1994; 6:1273-1277.
25. Premack BA and Schall TJ: Chemokine receptors: Gateways to inflammation and infection. Nature Med 1996;2:1174-1178.
26. Scala E, D'Offizi G, Rosso R, Turriziani O, Ferrara R, Mazzone AM, Antonelli G, Aiuti F, and Paganelli R: C-C chemokines, IL-16, and soluble antiviral factor activity are increased in cloned T cells from subjects with long-term nonprogressive HIV infection. J Immunol 1997;158:4485-4492.
27. +, T-cell clones correlates with the clinical state of human immunodeficiency virus type 1 (HIV-1)-infected individuals and may be responsible for blocking infection with non-syncytium-inducing HIV-1 in vitro. J Virol 1998;72:876-881.
28. Loetscher P, Seitz M, Baggiolini M, and Moser B: Interleukin-2 regulates CC chemokine receptor expression and chemotactic responsiveness in T lymphocytes. J Exp Med 1996;184:569-577.
29. + CTL clones from patients with HTLV-I-associated neurologic disease secrete proinflammatory cytokines, chemokines, and matrix metalloproteinase. J Immunol 1997;159:2018-2025.
30. Baba M, Imai T, Yoshida T, and Yoshie O: Constitutive expression of various chemokine genes in human T-cell lines infected with human T-cell leukemia virus type 1: Role of the viral transactivator Tax. Int J Cancer 1996;66:124-129.
31. Amara A, Gall SL, Schwartz O, Salamero J, Montes M, Loetscher P, Baggiolini M, Virelizier JL, and Arenzana-Seisdedos F: HIV coreceptor downregulation as antiviral principle: SDF-1α-dependent internalization of the chemokine receptor CXCR4 contributes to inhibition of HIV replication. J Exp Med 1997;186:139-146.
32. Aramori I, Zhang J, Ferguson SSG, Bieniasz PD, Cullen BR, and Caron MG: Molecular mechanism of desensitization of the chemokine receptor CCR-5: Receptor signaling and internalization are dissociable from its role as an HIV-1 co-receptor. EMBO J 1997;16:4606-4616.
33. Mack M, Luckow B, Nelson PJ, Cihak J, Simmons G, Clapham PR, Signoret N, Marsh M, Stangassinger M, Borlat F, Wells TNC, Schlondorff D, and Proudfoot AEI: Aminooxypentane-RANTES induces CCR5 internalization but inhibits recycling: A novel inhibitory mechanism of HIV infectivity. J Exp Med 1998;187: 1215-1224.
34. Zhao J, Ma L, Wu YL, Wang P, Hu W, and Pei G: Chemokine receptor CCR5 functionally couples to inhibitory G proteins and undergoes desensitization. J Cell Biochem 1998;71:36-45.
35. + T-cell-derived soluble factor(s), but not β-chemokines RANTES, MIP-1α, and MIP-1β, suppress HIV-1 replication in monocyte/macrophages. Proc Natl Acad Sci USA 1996;93:15341-15345.
36. Moriuchi H, Moriuchi M, and Fauci AS: Factors secreted by human T lymphotropic virus type I (HTLV-I)-infected cells can enhance or inhibit replication of HIV-1 in HTLV-I-uninfected cells: Implications for in vivo coinfection with HTLV-I and HIV-1. J Exp Med 1998;187:1689-1697.
37. Dolei A, Biolchini A, Serra C, Curreli S, Gomes E, and Dianzani F: Increased replication of T-cell-tropic HIV strains and CXC-chemokine receptor-4 induction in T cells treated with macrophage inflammatory protein (MIP)-1α, MIP-1β and RANTES β-chemokines. AIDS 1998;12:183-190.
38. + T cells: Role of signal transduction. Proc Natl Acad Sci USA 1998;95:11880-11885.